Verition Fund Management LLC Apellis Pharmaceuticals, Inc. Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$76.68 - $93.31 $26,607 - $32,378
347 Added 9.51%
3,997 $364,000
Q1 2023

May 15, 2023
BUY
$46.59 - $66.96 $170,053 - $244,403
3,650 New
3,650 $240,000
Q2 2022

Aug 15, 2022
SELL
$35.07 - $59.21 $1.67 Million - $2.82 Million
-47,640 Reduced 90.06%
5,259 $238,000
Q1 2022

May 13, 2022
SELL
$35.46 - $54.12 $1.12 Million - $1.71 Million
-31,594 Reduced 37.39%
52,899 $2.69 Million
Q4 2021

Feb 14, 2022
BUY
$30.74 - $49.16 $2.6 Million - $4.15 Million
84,493 New
84,493 $4 Million
Q3 2021

Nov 15, 2021
SELL
$31.4 - $69.84 $611,577 - $1.36 Million
-19,477 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$40.9 - $64.9 $219,837 - $348,837
5,375 Added 38.12%
19,477 $1.23 Million
Q1 2021

May 18, 2021
BUY
$40.8 - $57.39 $575,361 - $809,313
14,102 New
14,102 $605,000
Q3 2020

Nov 16, 2020
SELL
$25.89 - $33.65 $2.56 Million - $3.33 Million
-99,045 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$24.8 - $38.49 $1.43 Million - $2.22 Million
57,656 Added 139.3%
99,045 $3.24 Million
Q1 2020

May 15, 2020
BUY
$17.91 - $44.33 $331,442 - $820,370
18,506 Added 80.87%
41,389 $1.11 Million
Q4 2019

Feb 14, 2020
BUY
$22.1 - $30.8 $505,714 - $704,796
22,883 New
22,883 $701,000

Others Institutions Holding APLS

# of Institutions
310
Shares Held
113M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.29B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email